Key Product Details
Description: | Very potent and selective β3 partial agonist |
Chemical Name: | 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-benzenesulfonamide |
Purity: | ≥98% (HPLC) |
Molecular Weight: | 584.73 |
Customers also Viewed
Customers also Purchased
Citations for L-755,507 (6)
Citations are publications that use Bio-Techne products. Selected citations for L-755,507 include:
-
Riesenberg and Maricic
(2018)
Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells.
Nat Commun.
9:2164
PMID: 29867139 -
Kornete et al.
(2018)
Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells.
J Immunol.
200:2489
PMID: 29445007 -
Pinder et al.
(2015)
Nuclear domain 'knock-in' screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing.
Nucleic Acids Res.
43:9379
PMID: 26429972 -
Afeli et al.
(2012)
Do β3-adrenergic receptors play a role in guinea pig detrusor smooth muscle excitability and contractility?.
Am J Physiol Renal Physiol.
302:F251
PMID: 21993887 -
Coan et al.
(2009)
Promiscuous aggregate-based inhibitors promote enzyme unfolding.
J Med Chem.
52:2067
PMID: 19281222 -
Coan and Shoichet
(2008)
Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.
J Am Chem Soc.
130:9606
PMID: 18588298
There are no citations that match your criteria.